Evidence map›Paper›PMID 29720245›Full record

ArticleStem cell research & therapy2018

Human platelet lysate in mesenchymal stromal cell expansion according to a GMP grade protocol: a cell factory experience.

Valentina Becherucci, Luisa Piccini, Serena Casamassima, Silvia Bisin, Valentina Gori, Francesca Gentile, Riccardo Ceccantini, Elena De Rienzo, Barbara Bindi, Paola Pavan and 6 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 2 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 2 syntheses or guidelines pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Valentina BecherucciCell Factory Meyer, "A. Meyer" University Children's Hospital, Florence, Italy. valentina.becherucci@meyer.it.ORCID 0000-0002-2711-0088
Luisa PicciniCell Factory Meyer, "A. Meyer" University Children's Hospital, Florence, Italy.
Serena CasamassimaCell Factory Meyer, "A. Meyer" University Children's Hospital, Florence, Italy.
Silvia BisinCell Factory Meyer, "A. Meyer" University Children's Hospital, Florence, Italy.
Valentina GoriCell Factory Meyer, "A. Meyer" University Children's Hospital, Florence, Italy.
Francesca GentileCell Factory Meyer, "A. Meyer" University Children's Hospital, Florence, Italy.
Riccardo CeccantiniCell Factory Meyer, "A. Meyer" University Children's Hospital, Florence, Italy.
Elena De RienzoCell Factory Meyer, "A. Meyer" University Children's Hospital, Florence, Italy.
Barbara BindiTransfusion Medicine and Cell Therapy Unit, "A. Meyer" University Children's Hospital, Florence, Italy.
Paola PavanTransfusion Medicine and Cell Therapy Unit, "A. Meyer" University Children's Hospital, Florence, Italy.
Vanessa CunialTransfusion Medicine and Cell Therapy Unit, "A. Meyer" University Children's Hospital, Florence, Italy.
Elisa AllegroTransfusion Medicine and Cell Therapy Unit, "A. Meyer" University Children's Hospital, Florence, Italy.
Stefano ErminiTransfusion Medicine and Cell Therapy Unit, "A. Meyer" University Children's Hospital, Florence, Italy.
Francesca BrugnoloCell Factory Meyer, "A. Meyer" University Children's Hospital, Florence, Italy.
Giuseppe AstoriAdvanced Cellular Therapy Laboratory, Department of Cellular Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy.
Franco BambiCell Factory Meyer, "A. Meyer" University Children's Hospital, Florence, Italy.
Meyer Children's Hospital · ITOspedale San Bortolo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe use of platelet lysate (PL) for the ex-vivo expansion of mesenchymal stromal/stem cells (MSCs) was initially proposed by Doucet et al. in 2005, as an alternative to animal serum. Moreover, regulatory authorities discourage the use of fetal bovine serum (FBS) or other animal derivatives, to avoid risk of zoonoses and xenogeneic immune reactions. Even if many studies investigated PL composition, there still are some open issues related to its use in ex-vivo MSC expansion, especially according to good manufacturing practice (GMP) grade protocols.

methodsAs an authorized cell factory, we report our experience using standardized PL produced by Azienda Ospedaliero Universitaria Meyer Transfusion Service for MSC expansion according to a GMP grade clinical protocol. As suggested by other authors, we performed an in-vitro test on MSCs versus MSCs cultured with FBS that still represents the best way to test PL batches. We compared 12 MSC batches cultured with DMEM 5% PL with similar batches cultured with DMEM 10% FBS, focusing on the MSC proliferation rate, MSC surface marker expression, MSC immunomodulatory and differentiation potential, and finally MSC relative telomere length.

resultsResults confirmed the literature data as PL increases cell proliferation without affecting the MSC immunophenotype, immunomodulatory potential, differentiation potential and relative telomere length.

conclusionsPL can be considered a safe alternative to FBS for ex-vivo expansion of MSC according to a GMP grade protocol. Our experience confirms the literature data: a large number of MSCs for clinical applications can be obtained by expansion with PL, without affecting the MSC main features. Our experience underlines the benefits of a close collaboration between the PL producers (transfusion service) and the end users (cell factory) in a synergy of skills and experiences that can lead to standardized PL production.

Indexed as

Blood PlateletsCell Culture TechniquesCell DifferentiationCulture MediaHumansMesenchymal Stem CellsCulture MediaAdvanced therapy medicinal productsCell factoryFetal bovine serumGood manufacturing practiceMesenchymal stromal/stem cellsPlatelet lysate

Identifiers

PMID29720245
PMCPMC5930506
OpenAlexW2806102951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.